Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination

2024; Elsevier BV; Volume: 54; Issue: 5 Linguagem: Inglês

10.1016/j.idnow.2024.104886

ISSN

2666-9927

Autores

Christine Durier, Läétitia Ninove, Sylvie van der Werf, M. Lefèbvre, Corinne Desaint, Rebecca Bauer, Mikaël Attia, Anne-Sophie Lecompte, Marie Lachâtre, Z. Maakaroun-Vermesse, Jean–François Nicolas, Renaud Verdon, Jean‐Jacques Kiladjian, Paul Loubet, Catherine Schmidt‐Mutter, V. Corbin, Séverine Ansart, Giovanna Melica, Martine Resch, Emmanuelle Netzer, Yousra Kherabi, Raphaëlle Tardieu, Jean‐Daniel Lelièvre, Éric Tartour, Laurence Meyer, Xavier de Lamballerie, Odile Launay,

Tópico(s)

SARS-CoV-2 detection and testing

Resumo

COVID-19 vaccine breakthrough infections were frequently reported during circulation of the Omicron variant. The ANRS|MIE CoviCompareP study investigated these infections in adults vaccinated and boosted with BNT162b2 [Pfizer-BioNTech] and with/without SARS-CoV-2 infection before vaccination.

Referência(s)